Treating PAD and Diabetes: How the NOACs Can Help
- Have increased knowledge regarding the
- Current treatment approaches for patients with PAD and diabetes;
- Emerging role of NOACs in the setting of PAD and diabetes.
Associate Professor of Cardiology
Director of Vascular Research
University of Colorado School of Medicine
Executive Director. The CPC
Medical Director, Eastern Region
Inova Heart and Vascular Institute
Inova Alexandria Hospital
Chief, Division of Cardiology
Division of Clinical Pharmacology
Durham, North Carolina
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
Other Healthcare Professions Credit